WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'2701 Infant (under 12 months) mortality rate: 612
GDP / capita (US$): 2'7111 Child (under 5 years) mortality rate: 952

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 22'254  21'700  21'156  20'624  20'104  15'928  12'070  8'932 
Births 831  820  809  798  786  658  540  412 
Surviving infants 770  759  747  735  723  600  490  370 
Pop. less than 5 years 3'630  3'572  3'510  3'441  3'379  2'758  2'258  1'635 
Pop. less than 15 years 9'560  9'359  9'157  8'954  8'769  7'212  5'586  3'991 
Female 15-49 years 5'283  5'133  4'988  4'847  4'703  3'564  2'609  1'971 

Number of reported case

(Click for retrospective incidence data for Cameroon)
Diphtheria
Japanese encephalitis
Measles 760  609  504  240  251  14'629  21'150 
Mumps
Pertussis 5'498 
Polio* 38  255 
Rubella 148  147  106  48  33 
Rubella (CRS)
Tetanus (neonatal) 43  23  31  29  39  279  382 
Tetanus (total) 43  23  93  83  72  279  382 
Yellow fever 15  31  29  16  173 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cameroon)
Vaccine year result method % card seen                                                
BCG 2010  87  DHS   57  82  81  80  83  79  69  52 
DTP1 2010  86  DHS   57  95  94  90  92  88  54 
DTP3 2010  68  DHS   57  89  85  82  84  80  53  36 
HepB_BD         
HepB3 2010  65  DHS   57  89  85  82  84  80 
Hib3 2010  78     63  89  85  82  84  80 
JapEnc         
MCV 2010  71  DHS   57  83  82  76  79  74  49  36 
MCV2         
PCV1          95  92  89 
PCV3          88  84  70 
Pol3 2010  70  DHS   57  88  85  80  83  79  49  34 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  59  DHS   57  68  65  69  74  73  40  12 
PAB         
VAD1          86  73  76  85  83 
YFV 2010  69  DHS   57  83  80  75  79  72 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cameroon)
BCG 82  81  80  83  81  78  76 
DTP1 95  94  90  92  88  66  70 
DTP3 89  85  82  84  80  62  48 
HepB3 89  85  82  84  80 
HepB_BD
Hib3 89  85  82  84  80 
MCV 83  82  76  79  74  49  56 
MCV2
PAB 85  85  75  91  91  54  19 
PnC3 88  84  23 
Pol3 88  85  80  83  79  57  54 
Rota_last
YFV 83  80  75  79  72 

Number of districts in the country 181  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 54
From 80 to 89% 24
From 50 to 79% 22
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV No From November 2014
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes from March 2014
TT 1st contact; +1, +6 months; +1, +2 years; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes 6-59 months and postpartum
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2007-2011  2007-2011  2007-2011   
Nº of districts with microplans that include activities to raise immunization coverage number 180  169  179  112  NA     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  NA  No       

System performance

Total Nº districts in country number 181  181  179  179  173  173  171 
Nº districts with DTP3 coverage >=80% number 142  135  118  116  89  103  41 
% of districts with DTP3 coverage >=80% From 0 to 100% 78  75  66  65  51  60  24 
Nº districts with measles (MCV1) coverage >=95% number 44  51  33  32  18  36   
% of districts with MCV1 coverage >=95% From 0 to 100% 24  28  18  18  10  21   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 12  13  96  34  51  40 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.